SOURCE: Threshold Pharmaceuticals

Threshold Pharmaceuticals

September 22, 2011 16:15 ET

Threshold Pharmaceuticals to Present at the JMP Securities Healthcare Conference

SOUTH SAN FRANCISCO, CA--(Marketwire - Sep 22, 2011) - Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that Dr. Barry Selick, Threshold's Chief Executive Officer, is scheduled to present at the JMP Securities Healthcare Conference in New York City on Tuesday, September 27, 2011 at 10:00 AM EDT.

About Threshold Pharmaceuticals

Threshold is a biotechnology company focused on the discovery and development of drugs targeting Tumor Hypoxia, the low oxygen condition found in microenvironments of most solid tumors as well as the bone marrows of some hematologic malignancies. This approach offers broad potential to treat a variety of cancers. By selectively targeting tumor cells, we are building a pipeline of drugs that hold promise to be more effective and less toxic to healthy tissues than conventional anticancer drugs. For additional information, please visit our website (www.thresholdpharm.com).

Contact Information

  • Contact:
    Joel A. Fernandes
    Threshold Pharmaceuticals, Inc.
    650.474.8273
    Email Contact